Driving long term value from biotech platform deals

Michael Ward
Global Head of LS&H Thought Leadership
Clarivate
Helen Tayton-Martin
Chief Business Officer & Co-Founder
Adaptlmmune
Kendra Rose
VP and Head of New Platforms, Ophthalmology and Hemophilia
Bayer
Faical Miyara
Head of Global Partnering Oncology
Ipsen